Skip to main content
. 2010 Aug 3;8:79. doi: 10.1186/1477-7525-8-79

Table 2.

EORTC QLQ-C30 scores for the pre-, post- and then-test

n Pre-test (T1),
mean (SD)
pα Post-test (T2),
mean (SD)
pβ Then-test,
mean (SD)
Pain*
improved 58 52.6 (32.7) < 0.01 37.9 (27.5) < 0.01 55.5 (24.5)
unchanged 126 28.7 (27.8) 0.29 27.6 (28.0) < 0.01 22.5 (26.1)
deteriorated 50 46.0 (27.7) < 0.01 63.3 (28.6) < 0.01 36.3 (31.0)
Fatigue*
improved 56 51.0 (22.9) < 0.01 37.5 (21.4) < 0.01 51.4 (23.3)
unchanged 119 40.4 (24.6) 0.17 38.7 (26.1) < 0.01 34.2 (25.4)
deteriorated 58 56.3 (25.3) 0.01 64.0 (23.7) < 0.01 43.5 (25.3)
Physical function
improved 73 59.9 (22.3) < 0.01 66.3 (20.4) < 0.01 57.5 (24.2)
unchanged 96 69.7 (21.9) 0.77 70.4 (21.5) 0.15 71.7 (22.7)
deteriorated 58 60.8 (22.6) < 0.01 48.1 (21.2) < 0.01 68.3 (21.9)
Quality of life
improved 79 59.0 (26.1) < 0.01 66.6 (21.0) < 0.01 51.9 (19.5)
unchanged 110 64.2 (22.1) 0.69 64.5 (21.5) 0.44 63.2 (20.1)
deteriorated 49 48.6 (20.9) < 0.01 36.6 (20.2) < 0.01 48.8 (16.0)

*For the symptom scales pain and fatigue, higher scores represent more symptoms or difficulties

For the physical function and global quality of life scales, higher scores mean better functioning

SD: Standard deviation

pα -values denote differences between scale-means at T1 and T2

pβ -values denote differences between scale-means at T2 and then-test